REFERENCES
- Wilkie TL, Moore ES. Marketing's contributions to society. J Marketing. 1999; 63 (Special Issue):198–218.
- Spilker B. Multinational pharmaceutical companies: Principles and practices. 2nd ed. New York: Raven Press; 1994.
- The CDER handbook [resource on World Wide Web]. URL: http://www. fda.gov/cder/handbook/index.htm. Accessed 2001 Mar 26.
- Facts about the pharmaceutical industry [resource on World Wide Web]. URL: http://www.phrma.org/publications/backgrounders/development/invest.phtml. Accessed 2001 Mar 26.
- Trombetta W, Cavanagh J. Pharmaceutical marketing in transition. J Pharm Market Manage. 1997; 11(4):3–20.
- About compounding [resource on World Wide Web]. URL: http://www.pccarx. com/about_comp.htm. Accessed 2001 Mar 26.
- Sormedecker G, ed. Kremer and Urdang's history of pharmacy. 4th ed. Philadel-phia: J. B. Lippincott; 1976.
- Sackett DL, Haynes B, eds. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press; 1976.
- Kolassa EM. Elements of pharmaceutical pricing. Binghamton, NY: Haworth Press, Inc.; 1997.
- Zellmer WA. Rethinking hospital pharmaceutical marketing. Am J Health-Syst Pharm. 1995; 52:1590.
- Basara LR, Smith MC. Pharmacist perspectives on patient programs. Pharm Exec. 1995; 15(Nov): 83–6.
- Farmer K, Jacobs E. Pilot study of the impact on patient medication adherence by a company sponsored newsletter compliance program. APhA Annual Meeting 1995; 142(Mar):24.
- Casey MM, Maioli CM. Product support: Uplifting patients, payers and provid-ers. Pharm Exec 1996; 16(Feb):60–62, 64, 66.
- Gale B, Smith P, Wilson, P. Research databases for postmillennium health care. J Pharm Market Manage. 1996; 10(2/3):39–59.
- Morris L. Direct-to-Lou. Pharm Exec. 1999; 19(June Suppl):20.
- Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533–43.
- Zelnio RN, Bertram DK. A pharmaceutical marketing plan for the 21st century: Primary research prospects. J Pharm Market Manage. 1996; 10(2/3):61–107.